Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Expert Review of Vaccines
|
October 27, 2018
Personalized vaccination against ovarian cancer: what are the possibilities?
Janos L Tanyi, Erin George
Women'S Health (London, England)
|
October 29, 2013
Unintended consequences: surgical complications in gynecologic cancer
Sarah Horvath, Erin George, Thomas J Herzog
Diagnostics (Basel, Switzerland)
|
April 26, 2024
CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?
Clare Cutri-French, Dimitrios Nasioudis, Erin George, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2021
Humanized Patient-Derived Xenograft Models of Ovarian Cancer
Sarah B Gitto, Erin George, Sergey Medvedev, et al.
Frontiers in Big Data
|
April 2, 2026
Fairer non-negative matrix factorization
Lara Kassab, Erin George, Deanna Needell, et al.
Oncology Nursing Forum
|
July 4, 2012
One step at a time: self-management and transitions among women with ovarian cancer
Dena Schulman-Green, Elizabeth H Bradley, Nicholas R Nicholson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i>-Mutant Ovarian Cancer Models
Hyoung Kim, Erin George, Ryan Ragland, et al.
JCI Insight
|
August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target
Stefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
The Journal of Perinatal & Neonatal Nursing
|
April 27, 2022
Place of Birth Preferences and Relationship to Maternal and Newborn Outcomes Within the American Association of Birth Centers Perinatal Data Registry, 2007-2020
Diana R Jolles, Tiffany M Montgomery, Rachel Blankstein Breman, et al.
The Journal of Clinical Investigation
|
July 26, 2016
RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance
Yifan Wang, John J Krais, Andrea J Bernhardy, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Expert Review of Vaccines
|
October 27, 2018
Personalized vaccination against ovarian cancer: what are the possibilities?
Janos L Tanyi, Erin George
Women'S Health (London, England)
|
October 29, 2013
Unintended consequences: surgical complications in gynecologic cancer
Sarah Horvath, Erin George, Thomas J Herzog
Diagnostics (Basel, Switzerland)
|
April 26, 2024
CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?
Clare Cutri-French, Dimitrios Nasioudis, Erin George, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2021
Humanized Patient-Derived Xenograft Models of Ovarian Cancer
Sarah B Gitto, Erin George, Sergey Medvedev, et al.
Frontiers in Big Data
|
April 2, 2026
Fairer non-negative matrix factorization
Lara Kassab, Erin George, Deanna Needell, et al.
Oncology Nursing Forum
|
July 4, 2012
One step at a time: self-management and transitions among women with ovarian cancer
Dena Schulman-Green, Elizabeth H Bradley, Nicholas R Nicholson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i>-Mutant Ovarian Cancer Models
Hyoung Kim, Erin George, Ryan Ragland, et al.
JCI Insight
|
August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target
Stefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
The Journal of Perinatal & Neonatal Nursing
|
April 27, 2022
Place of Birth Preferences and Relationship to Maternal and Newborn Outcomes Within the American Association of Birth Centers Perinatal Data Registry, 2007-2020
Diana R Jolles, Tiffany M Montgomery, Rachel Blankstein Breman, et al.
The Journal of Clinical Investigation
|
July 26, 2016
RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance
Yifan Wang, John J Krais, Andrea J Bernhardy, et al.
Page
of 3